Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Re… (NCT05858489) | Clinical Trial Compass
CompletedNot Applicable
Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run)
Reunion61 participantsStarted 2023-04-14
Plain-language summary
Illeteracy concerns more than 38% of Réunion Island's people older than 65 years old, which makes it an important risk factor for dementia and a limit to neurocognitive test's administration.
The MMSRun is a Mini Mental State Examination's version adapted to illeteracy and Réunionese culture, inspired by Hindi Mental State Examination's work. It allows a way better participation during neurocognitive evaluation, but it has never been validated.
This study is a peliminary study to a validation, where the concordance between scores obtained from MMSRun and from the consensual version of Mini Mental State Examination proposed by GRECO (Groupe de Réflexion sur les Evaluations Cognitives) - the only french version validated - on a hospitalized and eldery population will be analyzed.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient who needs a cognitive evaluation by MMSe/MMS-RUN during usual medical care
* Patient born and living in Réunion Island
* Patient hospitalized in geriatrics department or in the departement of physical medecine and rehabilitation
* Patient who agrees to participate in the study and who does not oppose to the use of his data
Exclusion Criteria:
* Patient with hearing and visual disorder that can interfere in cognitive test administration
* Patient with altered state of consciousness (Glasgow score different of 15)
* Patient diagnosed or having symtoms compatible with a psychiatric pathology with psychosis (altered perception of reality)
* Patient with a current and severe addiction to Alcohol or any other drug (smoking excluded)
* Patient deprived of liberty by judicial or administrative decision and patient under curatorship or guardianship
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Total scoring of MMSE
Timeframe: Day 0
2
Total scoring of MMS-RUN
Timeframe: Day 1
Trial details
NCT IDNCT05858489
SponsorCentre Hospitalier Universitaire de la Réunion